scispace - formally typeset
H

Harald Stein

Researcher at Charité

Publications -  356
Citations -  53169

Harald Stein is an academic researcher from Charité. The author has contributed to research in topics: Lymphoma & Antigen. The author has an hindex of 96, co-authored 354 publications receiving 49817 citations. Previous affiliations of Harald Stein include University of Rostock & Franklin Institute.

Papers
More filters
Journal ArticleDOI

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

TL;DR: The revision clarifies the diagnosis and management of lesions at the very early stages of lymphomagenesis, refines the diagnostic criteria for some entities, details the expanding genetic/molecular landscape of numerous lymphoid neoplasms and their clinical correlates, and refers to investigations leading to more targeted therapeutic strategies.
Journal Article

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

TL;DR: The data suggest that the early stages of mitogen stimulation represent initial sequences of proliferation and not parts of the cell cycle, and immunostaining with monoclonal antibody Ki-67 provides a reliable means of rapidly evaluating the growth fraction of normal and neoplastic human cell populations.
Journal ArticleDOI

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

TL;DR: The APAAP technique was found particularly suitable for labeling cell smears and for detecting low numbers of antigen-bearing cells in a specimen and could be used in conjunction with immunoperoxidase methods for double immunoenzymatic staining.
Journal ArticleDOI

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

TL;DR: A first series of immunostainings of tumour biopsies indicated that Ki‐67 may be a potent tool for easy and quick evaluation of the proportion of proliferating cells in a tumour.